Zobrazeno 1 - 10
of 212
pro vyhledávání: '"J, Baratta"'
Autor:
Mateo Iwanowski, Jorge A. Bilbao, José M. Bonorino, Horacio E. Fernández, Renzo E. Melchiori, Nicolás A. Torres, Ricardo A. Costantini, José C. Santucci, Santiago N. Márquez Herrero, Pablo M. Rubio, Emilia M. Spaini, Guido M. García Juárez, Mateo Bivort Haiek, Guillermo N. Vaccarino, Sergio J. Baratta
Publikováno v:
REC: Interventional Cardiology, Vol 4, Iss 3, Pp 199-206 (2022)
RESUMEN Introducción y objetivos: Los pacientes con tromboembolia pulmonar (TEP) aguda hemodinámicamente inestables son candidatos para recibir trombolisis sistémica (TS); sin embargo, el tratamiento guiado por catéter (TGC) y la trombectomía qu
Externí odkaz:
https://doaj.org/article/5aa930c2cab2418ca2b9386baa0ee24b
Autor:
Mateo Iwanowski, Jorge A. Bilbao, José M. Bonorino, Horacio E. Fernández, Renzo E. Melchiori, Nicolás A. Torres, Ricardo A. Costantini, José C. Santucci, Santiago N. Márquez Herrero, Pablo M. Rubio, Emilia M. Spaini, Guido M. García Juárez, Mateo Bivort Haiek, Guillermo N. Vaccarino, Sergio J. Baratta
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 4, Iss 3, Pp 199-206 (2022)
Abstract Introduction and objectives: Hemodynamically unstable patients with acute pulmonary embolism (PE) are eligible for systemic thrombolysis (ST). However, catheter-directed therapy (CDT) and surgical thrombectomy (SUT) can also be considered wi
Externí odkaz:
https://doaj.org/article/dec4e951bfcc4e809f90f71fa297056d
Autor:
Andrés N. Atamañuk, Diego F. Litewka, Sergio J. Baratta, Ignacio M. Seropian, Graciela Perez Prados, Miguel O. Payaslian, Juan P. Ortiz Fragola, Pilar Escribano Subias
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background There is little information about vitamin D (Vit D) deficiency in patients with pulmonary hypertension (PH). The objective of this study was: 1) compare Vit D levels between patients with PH, left ventricular failure (LVF) and hea
Externí odkaz:
https://doaj.org/article/4d6921e7e165424e82a6f2db0a9f9b2b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Scott A. Tomlins, James M. Rae, Daniel F. Hayes, Ben H. Park, Michael D. Johnson, Farideh Z. Bischoff, Arul M. Chinnaiyan, Dan R. Robinson, Robert Lonigro, Yi-Mi Wu, Anne F. Schott, Christina Gersch, Dafydd G. Thomas, Nahomi Tokudome, Valeria Sero, Allen R. Blevins, Maryam Yazdani, David Chu, Chia-Jen Liu, Paul J. Baratta, Emily M. Cannell, Elizabeth P. Darga, Kimberly Aung, Daniel H. Hovelson, Jose M. Larios, Andi K. Cani, Costanza Paoletti
Addressing drug resistance is a core challenge in cancer research, but the degree of heterogeneity in resistance mechanisms in cancer is unclear. In this study, we conducted next-generation sequencing (NGS) of circulating tumor cells (CTC) from patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a18b5cd5f96f693020b929a06018a2
https://doi.org/10.1158/0008-5472.c.6510609.v1
https://doi.org/10.1158/0008-5472.c.6510609.v1
Autor:
Scott A. Tomlins, James M. Rae, Daniel F. Hayes, Ben H. Park, Michael D. Johnson, Farideh Z. Bischoff, Arul M. Chinnaiyan, Dan R. Robinson, Robert Lonigro, Yi-Mi Wu, Anne F. Schott, Christina Gersch, Dafydd G. Thomas, Nahomi Tokudome, Valeria Sero, Allen R. Blevins, Maryam Yazdani, David Chu, Chia-Jen Liu, Paul J. Baratta, Emily M. Cannell, Elizabeth P. Darga, Kimberly Aung, Daniel H. Hovelson, Jose M. Larios, Andi K. Cani, Costanza Paoletti
Supplementary Figure S1. Clinical timelines. Clinical timelines and treatment from first diagnosis until enrollment into MI-CTC-ONCOSEQ for the 11 metastatic breast cancer patients; Supplementary Figure S2. Sanger sequencing of WGA CTC DNA and Wester
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9c2c0c16e842c1ccef93834228e8eef
https://doi.org/10.1158/0008-5472.22420287
https://doi.org/10.1158/0008-5472.22420287
Publikováno v:
Medicina. 82(6)
Advances in knowledge incorporated in the last decade have modified the treatment paradigm in most of the malignant hematological diseases. In particular, the introduction of Bruton tyrosine kinase inhibitors (BTKi) and other target drugs together wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a5440623dcff503ea39bc5c0f0a575a
https://pubmed.ncbi.nlm.nih.gov/36571531
https://pubmed.ncbi.nlm.nih.gov/36571531
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Farrukh T. Awan, Daniel Addison, Feras Alfraih, Sergio J. Baratta, Rodrigo Noronha Campos, María Silvana Cugliari, Yeow Tee Goh, Valery Alexandrovich Ionin, Stefanie Mundnich, Aaron L. Sverdlov, Constantine Tam, Loïc Ysebaert
Publikováno v:
Blood advances. 6(18)
Bruton’s tyrosine kinase inhibitors (BTKis) have altered the treatment landscape for chronic lymphocytic leukemia (CLL) by offering effective and well-tolerated therapeutic options. However, since the approval of ibrutinib, concern has risen regard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea6276db37ce9f563e92a6f6379d86b1
https://pubmed.ncbi.nlm.nih.gov/35790105
https://pubmed.ncbi.nlm.nih.gov/35790105
Autor:
Anthony J Baratta
Nuclear energy is the only low-carbon source of energy capable of producing 1,000s of MWs day in and day out, regardless of weather or time of day. The result is energy in the form of radiation and energy in the form of the motion of the resulting he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef42c0ecef02f7c4be3cd6b265492551
https://doi.org/10.1201/9780429243608-21
https://doi.org/10.1201/9780429243608-21